Preferred Label : fluorine radioisotopes;
MeSH definition : Unstable isotopes of fluorine that decay or disintegrate emitting radiation. F atoms
with atomic weights 17, 18, and 20-22 are radioactive fluorine isotopes.;
MeSH synonym : radioisotopes, fluorine;
MeSH annotation : F-17, 18, 20-22; for routine use as tracer, use no qualifiers; for routine use as tracer, use no qualifiers;
Is substance : O;
Origin ID : D005462;
UMLS CUI : C0016331;
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Indexing information
- CDP2230 [MeSH Supplementary Concept]
- GE-180 [MeSH Supplementary Concept]
- MK-0911 [MeSH Supplementary Concept]
- MK-6577 [MeSH Supplementary Concept]
- MNI-444 [MeSH Supplementary Concept]
- NS14490 [MeSH Supplementary Concept]
- PSS232 [MeSH Supplementary Concept]
- THK5351 [MeSH Supplementary Concept]
- mefway [MeSH Supplementary Concept]
- nifene [MeSH Supplementary Concept]
Manual BTNT mappings - CISMeF
Record concept(s)
Related MeSH Supplementary Concept(s)
See also
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Unstable isotopes of fluorine that decay or disintegrate emitting radiation. F atoms
with atomic weights 17, 18, and 20-22 are radioactive fluorine isotopes.
https://www.ema.europa.eu/en/medicines/human/EPAR/pylclari
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Fluorine F 18 Piflufolastat
Fluorine F 18 Piflufolastat
piflufolastat (18F)
drug approval
europe
adult
prostatic neoplasms
Positron-Emission tomography
FOLH1 protein, human
neoplasm recurrence, local
Presence of direct invasion by primary malignant neoplasm of prostate to periprostatic
tissue (observable entity)
neoplasm staging
fluorine radioisotopes
fluorine radioisotopes
radiopharmaceuticals
product surveillance, postmarketing
injections, intravenous
pregnancy
breast feeding
drug evaluation, preclinical
---
https://www.has-sante.fr/jcms/p_3368278/fr/radelumin-18f-psma-1007
2022
false
false
false
France
Fluorine F 18 PSMA-1007
insurance, health, reimbursement
prostatic neoplasms
neoplasm recurrence, local
PSMA-1007
Positron-Emission tomography
radiopharmaceuticals
fluorine radioisotopes
injections, intravenous
Biochemically Recurrent Prostate Carcinoma
PSMA-1007 (18F)
evaluation of the transparency committee
---
https://www.has-sante.fr/jcms/p_3337433/fr/radelumin-18f-psma-1007-cancer-de-la-prostate
https://www.has-sante.fr/jcms/p_3337451/fr/decision-n-2022-0144/dc/sem-du-28-avril-2022-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-radelumin
2022
false
false
false
France
neoplasm recurrence, local
Positron-Emission tomography
insurance, health, reimbursement
radiopharmaceuticals
fluorine radioisotopes
PSMA-1007
injections, intravenous
Fluorine F 18 PSMA-1007
guidelines for drug use
Biochemically Recurrent Prostate Carcinoma
PSMA-1007 (18F)
evaluation of the transparency committee
prostatic neoplasms
---
https://www.has-sante.fr/portail/jcms/c_2746207/fr/iasocholine
2017
false
false
false
false
France
French
evaluation of the transparency committee
radiopharmaceuticals
radiopharmaceuticals
fluorocholine (18F)
injections, intravenous
fluorocholine
fluorocholine
fluorine radioisotopes
fluorine radioisotopes
Outcome Assessment, Health Care
Positron-Emission tomography
neoplasm staging
choline
carcinoma, hepatocellular
---
http://www.has-sante.fr/portail/jcms/c_2746198/fr/prostatep
2017
false
false
false
France
French
drug information
injections, intravenous
radiopharmaceuticals
prostatic neoplasms
carcinoma, hepatocellular
Positron-Emission tomography
fluorocholine (18F)
fluorine radioisotopes
fluorocholine
insurance, health, reimbursement
neoplasm metastasis
adult
neoplasm recurrence, local
neoplasm staging
choline
choline
---
http://www.has-sante.fr/portail/jcms/c_2613577/fr/fluorocholine-cis-bio-international
2016
false
false
false
France
French
evaluation of the transparency committee
radiopharmaceuticals
radiopharmaceuticals
fluorocholine (18F)
injections, intravenous
neoplasm metastasis
prostatic neoplasms
fluorocholine
fluorocholine
fluorine radioisotopes
fluorine radioisotopes
Outcome Assessment, Health Care
Positron-Emission tomography
neoplasm recurrence, local
neoplasm staging
choline
choline
choline
neoplasm recurrence, local
neoplasm metastasis
---
http://www.has-sante.fr/portail/jcms/c_2624078/fr/fluorochol
2016
false
false
false
France
French
evaluation of the transparency committee
radiopharmaceuticals
radiopharmaceuticals
fluorocholine (18F)
injections, intravenous
neoplasm metastasis
prostatic neoplasms
carcinoma, hepatocellular
fluorocholine
fluorocholine
fluorine radioisotopes
fluorine radioisotopes
Positron-Emission tomography
neoplasm staging
choline
prostatic neoplasms
carcinoma, hepatocellular
---
http://www.has-sante.fr/portail/jcms/c_2014032/fr/iasocholine-chlorure-de-fluorocholine-18f-radiopharmaceutique-a-usage-diagnostique
2015
false
false
false
France
French
guidelines for drug use
evaluation of the transparency committee
radiopharmaceuticals
radiopharmaceuticals
fluorocholine (18F)
injections, intravenous
neoplasm metastasis
prostatic neoplasms
Metastatic Malignant Neoplasm in the Bone
carcinoma, hepatocellular
fluorocholine
fluorocholine
fluorine radioisotopes
fluorine radioisotopes
Outcome Assessment, Health Care
Positron-Emission tomography
bone neoplasms
choline
choline
choline
neoplasm metastasis
carcinoma, hepatocellular
---
http://www.has-sante.fr/portail/jcms/c_2014032/fr/iasocholine
2015
false
false
false
France
French
evaluation of the transparency committee
injections, intravenous
radiopharmaceuticals
fluorocholine
fluorine radioisotopes
fluorocholine (18F)
prostatic neoplasms
carcinoma, hepatocellular
bone neoplasms
bone neoplasms
neoplasm metastasis
Positron-Emission tomography
choline
choline
carcinoma, hepatocellular
neoplasm metastasis
bone neoplasms
---
http://www.has-sante.fr/portail/jcms/c_1748406/fr/naf-meta-trace
2014
false
false
false
France
French
evaluation of the transparency committee
Sodium fluoride (18-F) (substance)
Sodium fluoride (18-F) (substance)
fluorine radioisotopes
fluorine radioisotopes
sodium fluoride (18F)
injections, intravenous
Positron-Emission tomography
adult
child
neoplasm metastasis
bone neoplasms
bone neoplasms
radiopharmaceuticals
radiopharmaceuticals
fractures, bone
child abuse
low back pain
low back pain
adolescent
aged
Cancer Pain
neoplasm metastasis
low back pain
fractures, bone
child abuse
bone neoplasms
---
http://www.has-sante.fr/portail/jcms/c_1036283/iasoflu
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-03/iasoflu_-_ct-_9190.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-11/iasoflu_ct_9190.pdf
2011
France
French
English
Cancer Pain
Cancer Pain
Cancer pain
sodium fluoride
radiopharmaceuticals
fluorine radioisotopes
Positron-Emission tomography
adult
child
neoplasm metastasis
bone neoplasms
back pain
back pain
wounds and injuries
child abuse
injections, intravenous
sodium fluoride (18F)
treatment outcome
evaluation of the transparency committee
neoplasm metastasis
back pain
wounds and injuries
---
http://www.has-sante.fr/portail/jcms/c_1061975/iasoflu-fluorure-de-sodium-radiopharmaceutique-synthese-d-avis
http://www.has-sante.fr/portail/jcms/c_1036730/iasoflu-ct-9190
2011
France
French
evaluation of the transparency committee
guidelines for drug use
Cancer Pain
Cancer Pain
Cancer pain
sodium fluoride
radiopharmaceuticals
Positron-Emission tomography
fluorine radioisotopes
back pain
child abuse
neoplasm metastasis
adult
child
injections, intravenous
bone neoplasms
treatment outcome
sodium fluoride (18F)
child abuse
neoplasm metastasis
back pain
---
http://www.has-sante.fr/portail/jcms/c_1009681/cisnaf-fluorure-de-sodium-produit-radiopharmaceutique
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-10/cisnaf_-_ct-8536.pdf
2010
France
French
radiopharmaceuticals
sodium fluoride
Positron-Emission tomography
sodium fluoride (18F)
bone neoplasms
bone neoplasms
neoplasm metastasis
fluorine radioisotopes
injections, intravenous
adult
prostatic neoplasms
breast neoplasms
lung neoplasms
child
adolescent
treatment outcome
evaluation of the transparency committee
guidelines for drug use
bone neoplasms
neoplasm metastasis
---